Possible connection between intestinal tuft cells, ILC2s and obesity

被引:0
|
作者
Yang, Hong [1 ]
Huang, Yu-Xing [1 ,2 ]
Xiong, Pei-Yu [1 ]
Li, Jin-Qian [1 ]
Chen, Ji-Lan [1 ]
Liu, Xia [1 ]
Gong, Yan-Ju [1 ]
Ding, Wei-Jun [1 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
[2] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 14卷
基金
中国国家自然科学基金;
关键词
obesity; tuft cell (TC); group 2 innate lymphoid cell (ILC2); TC-ILC2; circuit; intestinal remodeling; immune homeostasis; INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR GATA3; HIGH-FAT DIET; BRUSH CELLS; MUCOSAL IMMUNITY; TYPE-2; IMMUNITY; G-PROTEIN; IL-25; EXPRESSION; PROMOTES;
D O I
10.3389/fimmu.2023.1266667
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intestinal tuft cells (TCs) are defined as chemosensory cells that can "taste" danger and induce immune responses. They play a critical role in gastrointestinal parasite invasion, inflammatory bowel diseases and high-fat diet-induced obesity. Intestinal IL-25, the unique product of TCs, is a key activator of type 2 immunity, especially to promote group 2 innate lymphoid cells (ILC2s) to secret IL-13. Then the IL-13 mainly promotes intestinal stem cell (ISCs) proliferation into TCs and goblet cells. This pathway formulates the circuit in the intestine. This paper focuses on the potential role of the intestinal TC, ILC2 and their circuit in obesity-induced intestinal damage, and discussion on further study and the potential therapeutic target in obesity.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Turning on ILC2s: diet control
    Magalhaes, Marlene
    Jackson-Jones, Lucy
    Benezech, Cecile
    IMMUNOLOGY AND CELL BIOLOGY, 2021, 99 (04) : 344 - 347
  • [22] ICOS regulates ILC2s in asthma
    Maazi, Hadi
    Akbari, Omid
    ONCOTARGET, 2015, 6 (28) : 24584 - 24585
  • [23] CD45 alleviates airway inflammation and lung fibrosis by limiting expansion and activation of ILC2s
    Cui, Guangwei
    Shimba, Akihiro
    Jin, Jianshi
    Hojo, Nozomi
    Asahi, Takuma
    Abe, Shinya
    Ejima, Aki
    Okada, Shinri
    Ohira, Keizo
    Kato, Ryoma
    Tani-ichi, Shizue
    Yamada, Ryo
    Ebihara, Takashi
    Shiroguchi, Katsuyuki
    Ikuta, Koichi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (36)
  • [24] Analysis of the percentages of monocyte subsets and ILC2s, their relationships with metabolic variables and response to hypocaloric restriction in obesity
    Figueroa-Vega, Nicte
    Marin-Aragon, Carolina I.
    Lopez-Aguilar, Itzel
    Ibarra-Reynoso, Lorena
    Perez-Luque, Elva
    Manuel Malacara, Juan
    PLOS ONE, 2020, 15 (02):
  • [25] Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma
    Verma, Mukesh
    Verma, Divya
    Alam, Rafeul
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 22 (01) : 29 - 35
  • [26] IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection
    Pelly, V. S.
    Kannan, Y.
    Coomes, S. M.
    Entwistle, L. J.
    Ruckerl, D.
    Seddon, B.
    MacDonald, A. S.
    McKenzie, A.
    Wilson, M. S.
    MUCOSAL IMMUNOLOGY, 2016, 9 (06) : 1407 - 1417
  • [27] ILC2s: New Actors in Tumor Immunity
    Ercolano, Giuseppe
    Falquet, Maryline
    Vanoni, Giulia
    Trabanelli, Sara
    Jandus, Camilla
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [28] ILC2s in infectious diseases and organ-specific fibrosis
    Kindermann, Markus
    Knipfer, Lisa
    Atreya, Imke
    Wirtz, Stefan
    SEMINARS IN IMMUNOPATHOLOGY, 2018, 40 (04) : 379 - 392
  • [29] Sources of ILC2s: diverse locations and precursors
    Sun, Xiao-Hong
    AGING-US, 2019, 11 (16): : 5874 - 5875
  • [30] Emerging roles of ILC2s in antitumor immunity
    Li, Zhao
    Sun, Hanxiao
    Gu, Zhitao
    Qiu, Ju
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1311 - 1313